>
pdufa.bio

VGX-3100

Updated ยทnext FDA decision on the calendar

VGX-3100 is a Inovio Pharmaceuticals program. Its next catalyst is a Readout in Dec 2026. Every date links its source.

INO catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Inovio Pharmaceuticals (INO). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Dec 2026INO

Questions

When is VGX-3100's next FDA decision or readout?

The next tracked catalyst for VGX-3100 is a Readout in Dec 2026.

What happened at VGX-3100's most recent FDA decision?

No FDA decision for VGX-3100 is in our archive yet.

Who makes VGX-3100?

Inovio Pharmaceuticals (INO).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.